TickerStat.com

Crinetics Pharmaceuticals, Inc. (CRNX)

Price—Loading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

10 annual periodsNewest to oldest
2025202420232022202120202019201820172016
Revenue$7.7M$1.0M$4.0M$0$0$71,000$1.2M$2.4M$2.0M$589,000
Research & development$332.1M$240.2M$168.5M$130.2M$84.3M$57.0M$41.5M$24.5M$9.2M$5.1M
Operating expenses—$339.9M$226.6M$172.6M$108.8M$75.0M$55.0M$31.1M$11.2M$6.6M
Operating income−$516.8M−$338.9M−$222.6M−$167.9M−$107.7M−$75.0M−$53.8M−$28.7M−$9.1M−$6.0M
EBITDAderived−$512.9M−$336.1M−$221.5M−$166.9M−$106.8M−$74.0M−$52.9M−$28.2M−$9.0M−$6.0M
Net income−$465.3M−$298.4M−$214.5M−$163.9M−$107.6M−$73.8M−$50.4M−$27.1M−$9.2M−$6.0M
Basic EPSper diluted share-$4.95-$3.69-$3.69-$3.15-$2.80-$2.42-$2.09-$2.23-$6.68-$5.96
Diluted EPSper diluted share-$4.95-$3.69-$3.69-$3.15-$2.80-$2.42-$2.09-$2.23-$6.68-$5.96
Review source filings at SEC.gov ↗

Insider buys & sells

Jul 1, 2024–Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)49$23.92M disclosed value
49 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
Jun 17, 2026Form 4 · 10b5-1Okey StephanieDirectorSellCommon Stock608$36.22$22.0K6.4K
Jun 17, 2026Form 4 · 10b5-1Okey StephanieDirectorSellCommon Stock6.3K$35.62$224.1K7.0K
Apr 8, 2026Form 4 · 10b5-1Knight Jeff E.Chief Dev. & Operating OfficerSellCommon Stock85.2K$40.10$3.42M105.3K
Mar 16, 2026Form 4 · 10b5-1Knight Jeff E.Chief Operating OfficerSellCommon Stock4.0K$37.77$149.6K112.0K
Mar 16, 2026Form 4 · 10b5-1Knight Jeff E.Chief Operating OfficerSellCommon Stock6.0K$37.11$220.8K116.0K
Review ownership filings at SEC.gov ↗